Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medical suspended preparation and preparation method thereof

一种药品、贮药的技术，应用在药品悬挂剂及其制备领域

Active Publication Date: 2010-10-06
杨孟君
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The present invention successfully solves this major problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical suspended preparation and preparation method thereof
  • Medical suspended preparation and preparation method thereof
  • Medical suspended preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0100]The preparation method of the present invention includes: (1) taking one or more drugs, such as two or more drugs being compatible; (2) adding 1-10% of the adjuvant by weight of the drug, and the adjuvant is ultra-fine electrical Stone powder or ultra-fine titanium dioxide powder, particle size 100nm-10um, these two accessories are available in the market. The addition of the auxiliary materials in the present invention is more ideal for the preparation effect after the auxiliary materials are added. If these auxiliary materials are not added, the effect is not as good as the addition of the auxiliary materials. ③ Put it into the mixer at room temperature and pressure to mechanically mix to make the content (2). The mixing temperature is 15°C-25°C, preferably 20°C, and the mixing time is 30-60 minutes, preferably 45 minutes. ④ Pack the content (2) into the microporous carrier material layer (3) sheet according to the weight of 1-50 grams of different specifications and ...

Embodiment 1

[0105] The raw materials, sibutramine, levothyroxine, and the auxiliary materials, tourmaline ultrafine powder (particle size: 0.2um), are prepared in a ratio of 4:5:1, put into a mixer, mixed at a temperature of 15°C-25°C, and then sent to the mixer. Put it into the powder packing machine, pack it into small bags with 0.5-1um microporous carrier non-woven material, each bag has a net weight of 5 grams, and then put it into a porous square box made of ABS material and seal it. The lanyard, that is, the obesity suspension treatment product for human trials (abbreviated as OHD).

[0106] The preparation method of OHD for animal testing is the same as that for human testing products, but the net weight of each package is 0.5 grams.

[0107] The product of this embodiment is observed on the effect of reducing weight and lipid-lowering in rats, and the observation data on the therapeutic effect of obesity in humans are as follows:

[0108] A. Observation on the effect of OHD on we...

Embodiment 2

[0147] Take the raw material omeprazole, clarithromycin, bismuth citrate, and the extract of Ligustrum lucidum, and the auxiliary material tourmaline powder (particle size: 0.2um), prepare the ingredients according to the ratio of 2:2:2:3:1, and put them into the mixer. , carry out ordinary mixing at a temperature of 15℃-25℃, and then send it to the powder packing machine, sub-package it into small bags with 0.5-1um microporous carrier non-woven material, each bag has a net weight of 5 grams, and then put it into ABS The porous square box made of the material is sealed in the inside, and the hanging belt is fastened to make the ulcer disease suspension treatment product (abbreviated as NHD).

[0148] The clinical efficacy observation data of the above products on gastric and duodenal ulcer patients are as follows:

[0149] Clinical observation of NHD in the treatment of gastric and duodenal ulcers

[0150] 1. Case selection: 80 hospitalized patients were selected, all of whom...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medical suspended preparation and a preparation method thereof. The medical suspended preparation is used for treating and preventing diseases or regulating physiological functions through medical information without contacting human or animal body skins. The basic structure of the medical suspended preparation is composed of a medicament bank (1), a container (4) and a connecting piece (5). Contents (2) are medicaments having pharmacological activities. When the preparation is used in treatment, no medicinal material matters enter a human or animal body, so safety problem as well as the simulation of oral preparations to the gastrointestinal tract, the first-pass effect of the gastrointestinal tract, the drawbacks of pains, cross-infection risks and injection and infusion reactions of injections, the simulation and damage of transdermal patchs to skin, the damage of adhesive to skin, and the like are avoided. The product can be used repeatedly, so the consumption of medicaments is reduced greatly, medicament resources are saved, environmental pollution caused by pharmaceutical industry is reduced greatly, and ecological is protected. The preparation is simple, convenient and safe to use and is particularly suitable for treating the aged and weak, children, people with mental retardation and animals.

Description

technical field [0001] The present invention relates to a new dosage form of medicine, in particular to a medicine suspension and a preparation method thereof. Background technique [0002] Drugs are single compounds, biological products and compositions that are used directly in humans or animals for the purpose of diagnosing, treating and preventing human or animal diseases, purposefully modulating human or animal physiological functions, or directly using humans or animals for conception or contraception. Drugs must be in a certain dosage form for human or animal use, which is also a mode of administration. Traditional western medicines include injections, pills, tablets, ointments, suppositories, and transdermal patches, and traditional Chinese medicines include ointments, pills, pills, powders, strips, lozenges, teas, and liniments. In recent years, many controlled-release preparations have been invented on the basis of the above-mentioned traditional dosage forms, inc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61J1/00A61K9/00
CPCA61J1/00A45F5/00A61J1/1475A45F2005/006A61J3/00Y10T428/13
Inventor 杨孟君
Owner 杨孟君
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com